Tesco
Decoding Big Pharma’s Secret Drug Pricing Practices
Report

Decoding Big Pharma’s Secret Drug Pricing Practices

Robert Langreth, Michael Keller and Christopher Cannon
Bloomberg, 2016
Get the Report

Read or listen offline

áudio gerado automaticamente
  • 0.5×
  • 0.75×
  • 1×
  • 1.25×
  • 1.5×
  • 1.75×
1×
áudio gerado automaticamente

Editorial Rating

8

Qualities

  • Innovative

Recommendation

Given that the list prices for brand-name medications don’t reflect the negotiated prices insurers pay drug manufacturers, how can Americans get a true sense of the cost increases of drugs over time? Bloomberg reporters Robert Langreth, Michael Keller and Christopher Cannon attempt to answer this question via statistical analysis of drug price increases between 2009 and 2015. In the course of their research, the authors examine the degree to which price increases track with discounts and inflation. getAbstract recommends their findings to consumers and those working in the health care industry.

Take-Aways

  • List prices for name-brand drugs don’t reflect the adjusted prices health care providers pay.
  • Discounts for health care providers change over time as costs rise and as individual drugs face more or less competition.
  • In an analysis of 39 medications, 30 drugs increased in price “more than double the rate of inflation from 2009 to 2015.”

About the Authors

Robert Langreth is a science and health reporter, Michael Keller is an interactive news reporter, and Christopher Cannon is a data journalist and graphic designer for Bloomberg. 

Comment on this summary or Iniciar a Discussão